Fore Capital »

SPDR S&P Biotech shares owned by Fore Capital

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Fore Capital from 13F filings

Historical chart of Fore Capital investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Fore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Fore Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.5M 25k 98.80
2021-06-30 $677k 5.0k 135.40
2018-03-31 $18M 200k 90.65
2017-12-31 $2.6M 31k 84.87

More positions owned by Fore Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Silver Tr Ishares (SLV)
Ishares Gold Tr Ishares New (IAU)
Vaneck Etf Trust Gold Miners Etf Call Option (GDX)
Etsy Note 0.250% 6/1 (Principal)
H World Group Note 3.000% 5/0 (Principal)
Kraneshares Trust Csi Chi Internet Call Option (KWEB)
Ishares Tr China Lg-cap Etf Call Option (FXI)
Oil Sts Intl Note 4.750% 4/0 (Principal)
Ncl Corp Note 1.125% 2/1 (Principal)
Rapid7 Note 0.250% 3/1 (Principal)
Sprott Physical Gold & Silve Tr Unit (CEF)
Spdr Ser Tr S&p Biotech (XBI)
Zto Express Cayman Note 1.500% 9/0 (Principal)

View all positions for Fore Capital

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Bank of America Corporation
Citigroup
Jane Street
Citadel Advisors
Morgan Stanley
Susquehanna International
NWI Management
Bnp Paribas Arbitrage, Snc
Twin Tree Management
Parallax Volatility Advisers
Wells Fargo & Company
Logos Global Management

View all funds holding SPDR S&P Biotech